Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Endocyte Inc (NASDAQ:ECYT)

2.75
Delayed Data
As of 3:59pm ET
 -0.01 / -0.36%
Today’s Change
2.55
Today|||52-Week Range
4.43
-31.42%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Quarter
Trend
Quarter 4
2015
Quarter 1
2016
Quarter 2
2016
Quarter 3
2016
Revenue and IncomeNet Revenues12.0K12.5K12.5K32.5K
 
 
 
 
 
Depreciation And Amortization220.5K217.3K227.1K235.3K
 
 
 
 
 
 
Operating ExpensesGross Income----------
General Expenses9.7M10.1M14.0M8.7M
 
 
 
 
 
Research And Development6.4M6.5M6.8M6.0M
 
 
 
 
 
Total Operating Expenses9.9M10.4M14.2M9.0M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income-9.9M-10.3M-14.2M-8.9M
 
 
 
 
 
Other Expenses-55.0K-3.5K-860.00262.00
 
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-9.8M-10.2M-14.0M-8.7M
 
 
 
 
 
Net Income-9.8M-10.2M-14.0M-8.7M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS42.0M42.1M42.2M42.3M
 
 
 
 
 
Shares To Calculate EPS Diluted42.0M42.1M42.2M42.3M
 
 
 
 
 
 
Earnings Per ShareEPS-$0.23-$0.24-$0.33-$0.21
 
 
 
 
 
EPS Diluted-$0.23-$0.24-$0.33-$0.21